| Title: |
Favorable Appendicular Skeletal Muscle Mass Changes in Older Patients With Type 2 Diabetes Receiving GLP-1 Receptor Agonist and Basal Insulin Co-Therapy. |
| Authors: |
Osaka, Takafumi1,2 (AUTHOR), Hamaguchi, Masahide1 (AUTHOR), Fukui, Michiaki1 (AUTHOR) michiaki@koto.kpu-m.ac.jp |
| Source: |
Clinical Medicine Insights: Endocrinology & Diabetes. 4/2/2023, p1-6. 6p. |
| Subject Terms: |
*INSULIN therapy, *COMBINATION drug therapy, *SKELETAL muscle, *RETROSPECTIVE studies, *SARCOPENIA, *TYPE 2 diabetes, *DIET therapy, *MUSCLE strength, *QUALITY of life, *DESCRIPTIVE statistics, *GLUCAGON-like peptide-1 agonists, *HEALTH self-care, *LONGITUDINAL method, *EXERCISE therapy, *OLD age |
| Abstract: |
Background And Aims: Maintaining appendicular skeletal muscle mass is important for maintaining the quality of life of elderly patients with type 2 diabetes. The possibility of GLP-1 receptor agonists for maintaining appendicular skeletal muscle mass has previously been reported. We investigated changes in appendicular skeletal muscle mass, measured by body impedance analysis, in elderly patients who were hospitalized for diabetes self-management education. Methods: The study design was a retrospective longitudinal analysis of the changes in appendicular skeletal muscle mass in hospitalized patients over the age of 70 years. The study subjects consisted of consequential patients who received GLP-1 receptor agonist and basal insulin co-therapy or received basal insulin therapy. Body impedance analysis was performed on the day after admission and on the ninth day of admission. All patients received standard diet therapy and standard group exercise therapy 3 times per week. Results: The study subjects consisted of 10 patients who received GLP-1 receptor agonist and basal insulin co-therapy (co-therapy group) and 10 patients who received basal insulin (insulin group). The mean change in appendicular skeletal muscle mass was 0.78 ± 0.7 kg in co-therapy group and −0.09 ± 0.8 kg in the insulin group. Conclusions: This retrospective observational study suggests the possibility of favorable effects of GLP-1 receptor agonist and basal insulin co-therapy for maintaining appendicular skeletal muscle mass during hospitalization for diabetes self-management education. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical Medicine Insights: Endocrinology & Diabetes is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
